Vaccine News and Research

Latest Vaccine News and Research

New mouse model technology in cancer vaccine tool-box

Cancer vaccines are being investigated in early-phase clinical trials around the world, with many of those trials recruiting patients with melanoma.

4 Apr 2006

New clinical trial to test different strengths of a vaccine designed to fight avian influenza

The Duke study is part of a multicenter trial that will test a modified form of an investigational bird flu vaccine to determine whether the vaccine still triggers a strong immune response at lower doses.

4 Apr 2006

Immune response protects against brain tumor development

In their quest to determine whether immune system surveillance guards against brain tumor development, researchers at The University of Texas M. D. Anderson Cancer Center have found that allergies and asthma that stimulate inflammation may be protective, but use of antihistamines to control the inflammation could eliminate that protection.

4 Apr 2006

British boy dies from measles

The death of a 13 year old boy in Britain from measles is the first fatality from the infection in 14 years and has ignited concern that the once common killer is back.

3 Apr 2006

High prevalence of mumps in Iowa

The Department of Public Health in Iowa says 245 confirmed, probable or suspected cases of mumps have been reported there since mid-January.

3 Apr 2006

Sweetgum tree may help fight bird flu

The sweetgum tree grows widely throughout the country and is known for its mace-like green fruit, which are sometimes called "gumballs." Now, this spiny fruit may become an important source of a chemical needed to make a lifesaving drug against bird flu - a drug that is currently in short supply worldwide, researchers say.

3 Apr 2006

HPV vaccines provide hope for major international programmes of primary prevention

Parents of young girls may soon be offered the opportunity to have their daughters immunised against a sexually transmitted virus that is the major cause of cervical cancer, the 4th International Conference on Teenage and Young Adult Cancer Medicine.

3 Apr 2006

Expecting enough bird flu vaccine for everyone is a big ask

According to researchers an experimental vaccine produced to offer protection against the H5N1 strain of bird flu presently causing havoc across the world, only appears to work at the very highest doses.

31 Mar 2006

Health experts meet in Asia to discuss preventing deadly childhood diseases

The deadly diseases pneumonia and meningitis kill an estimated 1.8 million children under the age of 5 years across the globe every year. Of these, more than 700,000 occur in the countries in the South-East Asia and Western Pacific regions of the World Health Organization (WHO).

30 Mar 2006

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

30 Mar 2006

Inducing melanoma for cancer vaccine development

Cancer vaccines are being investigated in early-phase clinical trials around the world, with many of those trials recruiting patients with melanoma.

28 Mar 2006

Flu vaccination program could save more than 6,500 lives

To increase influenza vaccinations rates among the elderly - those ages 65 and over who are at high risk for influenza-related mortality - the federal government could consider borrowing a page from the pharmaceutical companies' prescription drug advertising campaigns.

27 Mar 2006

It's time for Britain to adopt universal hepatitis B immunisation

The United Kingdom is one of the few developed countries that have not implemented universal immunisation. Instead, it follows a policy of selective immunisation of high-risk groups, and screening all women attending antenatal clinics.

27 Mar 2006

Phagocytosis depends more on particle shape than size

The research, which has far-reaching implications for immunology, vaccine development and drug delivery, is published today online in the Proceedings of the National Academy of Sciences by Samir Mitragotri, a UCSB professor of chemical engineering, and graduate student Julie A. Champion. The paper will be published in print on March 28.

23 Mar 2006

Immune system protein LL-37 critical in controlling replication of vaccinia virus

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have identified a defect in the immune response of people with the skin condition atopic dermatitis that puts them at risk of developing serious complications following smallpox vaccination.

23 Mar 2006

Potential therapeutic targets against serious side effects of smallpox vaccine

Smallpox is considered a potential terrorist weapon, but millions of people in the United States are currently advised not to get a vaccine to the disease because they are susceptible to developing a severe adverse reaction.

23 Mar 2006

There is little chance the U.S. will be able to manufacture enough vaccines to stop a bird flu pandemic

A group of medical experts who attended a national avian flu conference last fall believe there is little chance the United States will be able to manufacture and stockpile enough vaccine or antiviral medication to stop a bird flu pandemic should the virus mutate into a form that can be spread easily from human to human

23 Mar 2006

U.S. buys more Relenza and Tamiflu for future influenza pandemics

The United States Department of Health and Human Services has announced additional purchases of antiviral drugs that could be used in the event of a potential influenza pandemic.

23 Mar 2006

First evidence that dendritic cells show unprecedented sensitivity to thimerosal

A team of cell biologists, toxicologists and molecular bioscientists at UC Davis has published a study connecting thimerosal with disruptions in antigen-presenting cells known as dendritic cells obtained from mice.

22 Mar 2006

Swedish scientists move closer to a cancer vaccine

Scientists at Karolinska Institutet in Sweden have helped to identify a molecule that can be used as a vaccination agent against growing cancer tumours. Although the results are so far based on animal experiments, they point to new methods of treating metastases.

21 Mar 2006